WallStreetZenWallStreetZen

NASDAQ: RANI
Rani Therapeutics Holdings Inc Stock Ownership - Who owns Rani Therapeutics Holdings?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rani Therapeutics Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kate McKinleyChief Business Officer2024-12-1317,960$1.67
$29.99kBuy
Talat ImranChief Executive Officer2024-12-0910,296$1.94
$19.97kBuy
South Cone Investments Limited Partnership10% Owner2024-10-153,305,622$2.55
$8.44MSell
South Cone Investments Limited Partnership10% Owner2024-10-15523,738$3.26
$1.71MSell

1 of 1

RANI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RANI insiders and whales buy or sell their stock.

RANI Shareholders

What type of owners hold Rani Therapeutics Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
South Cone Investments Limited Partnership25.89%14,898,682$8.19MInsider
Moreno Isidoro Quiroga9.16%5,272,750$2.90MInsider
Armistice Capital LLC5.48%3,151,354$1.73MInstitution
Vanguard Group Inc1.39%799,679$439.82kInstitution
Talat Imran0.88%507,094$278.90kInsider
Nan Fung Group Holdings Ltd0.86%493,584$271.47kInstitution
Andrew Farquharson0.71%406,768$223.72kInsider
United Services Automobile Association0.53%302,743$166.51kInstitution
Mir Hashim0.47%273,265$150.30kInsider
Svai S. Sanford0.45%258,597$142.23kInsider

1 of 3

RANI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RANI11.22%38.43%Net Selling
PMN16.36%40.99%Net Buying
MURA47.53%3.28%Net SellingNet Selling
MEIP15.01%84.99%
NRSN1.83%0.00%
View Top Biotech Stocks

Rani Therapeutics Holdings Stock Ownership FAQ

Who owns Rani Therapeutics Holdings?

Rani Therapeutics Holdings (NASDAQ: RANI) is owned by 11.22% institutional shareholders, 38.43% Rani Therapeutics Holdings insiders, and 50.36% retail investors. South Cone Investments Limited Partnership is the largest individual Rani Therapeutics Holdings shareholder, owning 14.90M shares representing 25.89% of the company. South Cone Investments Limited Partnership's Rani Therapeutics Holdings shares are currently valued at $8.25M.

If you're new to stock investing, here's how to buy Rani Therapeutics Holdings stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.